Globe Life Inc. (NYSE:GL) Holdings Raised by Two Sigma Investments LP

Two Sigma Investments LP lifted its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 81.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 262,706 shares of the company's stock after purchasing an additional 118,321 shares during the quarter. Two Sigma Investments LP owned about 0.31% of Globe Life worth $29,297,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of GL. Albion Financial Group UT purchased a new position in Globe Life in the fourth quarter worth $28,000. Rakuten Securities Inc. purchased a new position in Globe Life in the fourth quarter worth $28,000. Avalon Trust Co purchased a new position in shares of Globe Life in the fourth quarter valued at $41,000. EverSource Wealth Advisors LLC increased its position in shares of Globe Life by 32.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock valued at $41,000 after buying an additional 90 shares in the last quarter. Finally, Platinum Investment Management Ltd. purchased a new position in shares of Globe Life in the fourth quarter valued at $45,000. Hedge funds and other institutional investors own 81.61% of the company's stock.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 6,019 shares of Globe Life stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $122.51, for a total transaction of $737,387.69. Following the sale, the chief executive officer now directly owns 31,298 shares in the company, valued at $3,834,317.98. The trade was a 16.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.51% of the company's stock.

Globe Life Trading Up 1.1%

NYSE:GL traded up $1.34 during mid-day trading on Tuesday, reaching $120.75. The company's stock had a trading volume of 100,320 shares, compared to its average volume of 660,044. The company's fifty day simple moving average is $122.62 and its two-hundred day simple moving average is $118.31. The stock has a market cap of $9.97 billion, a P/E ratio of 10.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. Globe Life Inc. has a twelve month low of $76.55 and a twelve month high of $133.76.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 EPS for the quarter, missing analysts' consensus estimates of $3.24 by ($0.17). The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.49 billion. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the business earned $2.78 earnings per share. On average, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Thursday, July 3rd will be issued a $0.27 dividend. The ex-dividend date is Thursday, July 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.89%. Globe Life's dividend payout ratio (DPR) is 8.79%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on GL shares. Morgan Stanley raised their price target on Globe Life from $117.00 to $125.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. Piper Sandler dropped their price target on Globe Life from $152.00 to $147.00 and set an "overweight" rating for the company in a research report on Friday, May 2nd. Keefe, Bruyette & Woods raised their price target on Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research report on Wednesday, February 12th. JPMorgan Chase & Co. raised their price target on Globe Life from $136.00 to $145.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Finally, Wall Street Zen raised Globe Life from a "hold" rating to a "buy" rating in a research note on Friday, May 16th. Four equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $137.73.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.